In the manufacturing of pharmaceutical products under the China-New Zealand FTA, origin cumulation allows active ingredients, excipients, and packaging materials from both countries to be combined to achieve the required origin threshold.
Source: https://www.trade.gov/china-new-zealand-fta-pharmaceuticals
Tools that match this term
You might also be interested in these terms
Analyze all 11 Incoterms 2020: cost matrix, risk timeline, insurance gap detector and customs responsibility – free, no login required.
Weekly: Top news, industry facts and insights from the world of logistics – free.
Content reviewed and editorially cleared.
Share your knowledge, ask follow-up questions, or add practical insights to this page. Every contribution is moderated before publication.